news.sky.com
NICE Recommends HRT for Menopause
NICE recommends HRT as the first-line treatment for menopausal symptoms, with CBT as an adjunct therapy.
English
United Kingdom
HealthLifestyleGender IssuesWomen's HealthTherapyHormonesMenopause Treatment
National Institute For Health And Care Excellence (Nice)
Professor Jonathan BengerMarie Anne Ledingham
- What is the overall emphasis of NICE's updated guidelines concerning menopause care?
- Individualized menopause care is crucial, allowing women to make informed choices about their treatment. NICE's updated guidance and discussion aid provide women with more information to make those choices.
- What are some of the risks and benefits of hormone replacement therapy (HRT) as highlighted by NICE?
- The revised guidelines highlight that while HRT slightly increases the risk of blood clots and breast cancer, it lowers osteoporosis risk. A 'discussion aid' provides data on these risks to help inform patient decisions.
- How does the updated NICE guidance differ from the previous draft guidance regarding the treatment of menopausal symptoms?
- The previous draft guidance controversially suggested CBT as an alternative to HRT, but the updated version clarifies CBT's role as an add-on therapy to complement HRT's effectiveness.
- What is the National Institute for Health and Care Excellence's (NICE) updated recommendation for treating menopausal symptoms?
- The National Institute for Health and Care Excellence (NICE) recommends hormone replacement therapy (HRT) as the first-line treatment for menopausal symptoms like hot flushes, insomnia, and low mood.
- What is the role of cognitive behavioral therapy (CBT) in the treatment of menopausal symptoms according to NICE's updated guidance?
- NICE's updated guidance emphasizes that HRT does not affect life expectancy and should be the primary treatment, with cognitive behavioral therapy (CBT) as an additional option for those who can't or don't want HRT.